PROLACTINOMA

PROLACTINOMA was reported 130 times

PROLACTINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 15 0.0030
1 Somatostatin Analog [EPC] 1 0.0001
2 Dopamine-2 Receptor Antagonist [EPC] 1 0.0001
3 Recombinant Human Growth Hormone [EPC] 2 0.0001
4 Atypical Antipsychotic [EPC] 28 0.0001
5 Provitamin D2 Compound [EPC] 1 0.0000
6 Mood Stabilizer [EPC] 7 0.0000
7 Sympathomimetic-like Agent [EPC] 1 0.0000
8 Estrogen [EPC] 5 0.0000
9 Interferon beta [EPC] 5 0.0000
10 Integrin Receptor Antagonist [EPC] 2 0.0000
11 Anti-IgE [EPC] 2 0.0000
12 Anti-epileptic Agent [EPC] 5 0.0000
13 Progestin [EPC] 6 0.0000
14 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
15 Methylxanthine [EPC] 1 0.0000
16 Cardiac Glycoside [EPC] 1 0.0000
17 Androgen Receptor Inhibitor [EPC] 1 0.0000
18 Nitrate Vasodilator [EPC] 1 0.0000
19 5-alpha Reductase Inhibitor [EPC] 1 0.0000
20 Aromatase Inhibitor [EPC] 1 0.0000
21 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
22 Benzodiazepine [EPC] 5 0.0000
23 alpha-Adrenergic Blocker [EPC] 1 0.0000
24 Calcium [EPC] 1 0.0000
25 Vitamin D [EPC] 2 0.0000
26 Loop Diuretic [EPC] 3 0.0000
27 beta-Adrenergic Blocker [EPC] 2 0.0000
28 Aldosterone Antagonist [EPC] 1 0.0000
29 Azole Antifungal [EPC] 1 0.0000
30 Vitamin B12 [EPC] 2 0.0000
31 Corticosteroid [EPC] 7 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
33 Platelet Aggregation Inhibitor [EPC] 3 0.0000
34 RANK Ligand Inhibitor [EPC] 1 0.0000
35 Vitamin C [EPC] 2 0.0000
36 Alkylating Drug [EPC] 1 0.0000
37 Osmotic Laxative [EPC] 1 0.0000
38 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
39 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
40 Insulin Analog [EPC] 1 0.0000
41 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
42 Proton Pump Inhibitor [EPC] 1 0.0000